Records containing: Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-07-27Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer: A Phase II Brown University Oncology Group Research Project
-
CLINICAL_TRIALS study record update · 2015-07-23Eight Week Plant-based Mediterranean Diet as Prevention of Metabolic Syndrome in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer: A BrUOG Pilot Study
-
CLINICAL_TRIALS study record update · 2015-07-22A Phase II Study of Proton-Based Radiation Therapy With Elective Pelvic Nodal Irradiation, Concomitant Docetaxel, and Adjuvant Androgen Deprivation for High-Risk Prostate Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2015-07-21A Phase 3, Multi-center, Randomized, Open-label, Parallel-group, Comparative Study of TAP-144-SR (3M) to Evaluate Hormone Dynamics, Pharmacokinetics, Safety and Efficacy of TAP-144-SR (6M) 22.5 mg Subcutaneous Injection for 48 Weeks in Prostate Cancer Patients Previously Treated With Hormonal Therapy
-
CLINICAL_TRIALS study record update · 2015-07-21A Randomized Phase II Dose Finding Study of ArginMax for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated With Radiotherapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-07-16Phase 1/2a, Open-Label, Dose-Escalation and Safety Study of APC-100 [Pentamethylchromanol, 2,2,5,7,8-Pentamethyl-6] in Men With Advanced Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-07-15Prostate Cancer Antigen-3 (PCA-3) and TMPRSS2-ERG (T2-ERG) Score Changes During Initiation of Androgen Deprivation Therapy (ADT) With Triptorelin 22.5mg in Patients With Advanced Prostate Cancer (PCA): A Phase III, Single Arm Multicentre Study
-
CLINICAL_TRIALS study record update · 2015-07-08Prospective, Multi-Center, Observational Program to Assess Routine Use of Intermittent Adjuvant Deprivation Therapy With Lucrin Depot in Patients With Advanced Prostate Cancer in the Russian Federation
-
CLINICAL_TRIALS study record update · 2015-07-07International, Prospective, Open-label, Multicenter, Pharmacoepidemiological Study to Determine Predictors of Clinical Outcomes in Chemotherapy-treated Cancer Patients at Risk for Febrile Neutropenia and Treated Prophylactically With Filgrastim Biosimilar.
-
CLINICAL_TRIALS study record update · 2015-06-29Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL) Following Radical Prostatectomy
-
CLINICAL_TRIALS study record update · 2015-06-24A Phase 1 Trial of Amplimexon® (Imexon, Inj.) Plus Taxotere® (Docetaxel) in Previously Treated Inoperable Stage III and Stage IV Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic Previously Treated Breast Cancer or Hormone Refractory Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-06-24A Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-06-23A Phase III Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer Prior to Prostatectomy or Brachytherapy
-
CLINICAL_TRIALS study record update · 2015-06-23A Phase II, Open-Label, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Omnitarg (Pertuzumab) in Subjects With Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-06-23An Open-label, Multi-centre, Randomised, Parallel-group Trial, Comparing Efficacy and Safety of Degarelix One-month Dosing Regimen With Goserelin in Chinese Patients With Prostate Cancer Requiring Androgen Ablation Therapy
-
CLINICAL_TRIALS study record update · 2015-06-23Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-06-16Cancer Information Service Research Consortium: Years 2006-2011 Program Narrative and Overview
-
CLINICAL_TRIALS study record update · 2015-06-16Prostate Cancer: Family Care for Patients and Spouses
-
CLINICAL_TRIALS study record update · 2015-06-16Tailored Web-Based Intervention for Cancer Patients and Family Caregivers
-
CLINICAL_TRIALS study record update · 2015-06-11Phase II Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients Undergoing Surgery or Radiation Therapy
-
CLINICAL_TRIALS study record update · 2015-06-08Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer
-
CLINICAL_TRIALS study record update · 2015-06-04Active Control of Prostatic Cancer With Criteria of Latence. Impact on Specific 10 Years Survival.
-
CLINICAL_TRIALS study record update · 2015-06-03An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
-
CLINICAL_TRIALS study record update · 2015-06-03H-25362: Effect of Botulinum Neurotoxin Type A Prostate Injections on Neurogenesis and Gene Profile Expression in Men With Localized Prostate Cancer and Lower Urinary Tract Symptoms/BPH (Protocol # 05-09-30-03)
-
CLINICAL_TRIALS study record update · 2015-06-03Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy (RPVE) in Prostate Cancer (PCA) Patients for Molecular Tumor Marker Analysis